Theratechnologies Inc. (TH.TO)
CAD 2.18
(0.46%)
CAD 2.18
(0.46%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 58.96 Million USD | -11.61% |
| 2022 | 66.71 Million USD | 17.56% |
| 2021 | 56.74 Million USD | 2.46% |
| 2020 | 55.38 Million USD | 9.15% |
| 2019 | 50.74 Million USD | 2.93% |
| 2018 | 49.29 Million USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | -100.0% |
| 1998 | 130.2 Thousand USD | 0.0% |
| 1997 | - USD | -100.0% |
| 1996 | 1.63 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 57.14 Million USD | -2.51% |
| 2024 Q1 | 59.14 Million USD | 0.29% |
| 2024 Q2 | 59.32 Million USD | 0.3% |
| 2023 Q1 | 65.98 Million USD | -1.09% |
| 2023 FY | 58.96 Million USD | -11.61% |
| 2023 Q4 | 58.96 Million USD | 1.25% |
| 2023 Q3 | 58.23 Million USD | -12.65% |
| 2023 Q2 | 66.67 Million USD | 1.04% |
| 2022 Q4 | 66.71 Million USD | 0.42% |
| 2022 FY | 66.71 Million USD | 17.56% |
| 2022 Q3 | 66.43 Million USD | 15.63% |
| 2022 Q2 | 57.45 Million USD | 0.6% |
| 2022 Q1 | 57.1 Million USD | 0.64% |
| 2021 Q3 | 56.44 Million USD | 0.42% |
| 2021 Q2 | 56.2 Million USD | 0.8% |
| 2021 FY | 56.74 Million USD | 2.46% |
| 2021 Q4 | 56.74 Million USD | 0.53% |
| 2021 Q1 | 55.76 Million USD | 0.68% |
| 2020 Q1 | 54.22 Million USD | 6.87% |
| 2020 Q4 | 55.38 Million USD | 0.62% |
| 2020 Q3 | 55.04 Million USD | 0.95% |
| 2020 Q2 | 54.52 Million USD | 0.56% |
| 2020 FY | 55.38 Million USD | 9.15% |
| 2019 Q1 | 49.59 Million USD | 0.6% |
| 2019 FY | 50.74 Million USD | 2.93% |
| 2019 Q2 | 49.96 Million USD | 0.76% |
| 2019 Q4 | 50.74 Million USD | 0.78% |
| 2019 Q3 | 50.34 Million USD | 0.76% |
| 2018 Q4 | 49.29 Million USD | 0.38% |
| 2018 FY | 49.29 Million USD | 0.0% |
| 2018 Q3 | 49.1 Million USD | 963.62% |
| 2018 Q2 | 4.61 Million USD | 0.0% |
| 2018 Q1 | - USD | -100.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q4 | 9.21 Million USD | 6.57% |
| 2017 Q3 | 8.65 Million USD | 0.0% |
| 2017 Q1 | 13.83 Million USD | 0.0% |
| 2017 Q2 | - USD | -100.0% |
| 2016 Q3 | - USD | -100.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q1 | 17.69 Million USD | 4.75% |
| 2016 Q2 | 12.41 Million USD | -29.85% |
| 2016 Q4 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q3 | - USD | -100.0% |
| 2015 Q4 | 16.89 Million USD | 0.0% |
| 2015 Q2 | 19.06 Million USD | -0.44% |
| 2015 Q1 | 19.14 Million CAD | 11.63% |
| 2014 FY | - USD | 0.0% |
| 2014 Q4 | 17.15 Million USD | 8.61% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | 15.79 Million USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2002 Q1 | - CAD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q3 | - CAD | 0.0% |
| 2002 Q2 | - CAD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 Q3 | - CAD | 0.0% |
| 2001 Q1 | - CAD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q2 | - CAD | 0.0% |
| 2001 Q4 | - CAD | 0.0% |
| 2000 Q1 | - CAD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 2000 Q4 | - CAD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 1999 Q1 | 66.29 Thousand USD | -49.09% |
| 1999 Q2 | 67.82 Thousand USD | 2.31% |
| 1999 FY | - USD | -100.0% |
| 1999 Q4 | - USD | 0.0% |
| 1999 Q3 | - USD | -100.0% |
| 1998 Q3 | 126.55 Thousand USD | -7.83% |
| 1998 Q2 | 137.3 Thousand USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q4 | 130.2 Thousand USD | 2.89% |
| 1998 FY | 130.2 Thousand USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 FY | - USD | -100.0% |
| 1997 Q2 | - USD | 0.0% |
| 1996 FY | 1.63 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | 104.79 Million CAD | 43.728% |
| Avicanna Inc. | 1.8 Million CAD | -3169.829% |
| Avant Brands Inc. | 18.7 Million CAD | -215.303% |
| Cardiol Therapeutics Inc. | 158.53 Thousand CAD | -37096.276% |
| Crescita Therapeutics Inc. | 1.25 Million CAD | -4602.392% |
| Knight Therapeutics Inc. | 69.09 Million CAD | 14.652% |
| MediPharm Labs Corp. | 2.29 Million CAD | -2469.412% |
| OrganiGram Holdings Inc. | 155 Thousand CAD | -37943.871% |
| Canopy Growth Corporation | 683.17 Million CAD | 91.368% |
| Willow Biosciences Inc. | 2.15 Million CAD | -2635.065% |
| Auxly Cannabis Group Inc. | 159.04 Million CAD | 62.924% |